Infliximab induces disease remission in patients with rheumatoid arthritis: Results from START clinical trial

被引：0
|
作者：
Yocum, D
Rahman, MU
Han, CL
Bala, M
Han, J
Westhovens, R
机构：
[1] Univ Arizona, Tucson, AZ USA
[2] Centocor Inc, Horsham, PA USA
[3] Univ Hosp Gasthuisberg, Dept Rheumatol, Louvain, Belgium
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S140 / S140
页数：1
相关论文
共 50 条
  • [21] Forefoot disease activity in rheumatoid arthritis patients in remission: results of a cohort study
    Marike van der Leeden
    Martijn PM Steultjens
    Dirkjan van Schaardenburg
    Joost Dekker
    Arthritis Research & Therapy, 12
  • [22] Comment on: Impact of interstitial lung disease on clinical remission of rheumatoid arthritis: results from the IORRA cohort
    Shih, Po-Cheng
    RHEUMATOLOGY, 2024, 63 (04) : e132 - e133
  • [23] Sustained Clinical Remission after Discontinuation of Infliximab with a Raising Dose Strategy in Patients with Rheumatoid Arthritis (RRRR study): A Randomized Controlled Trial
    Tanaka, Yoshiya
    Oba, Koji
    Koike, Takao
    Miyasaka, Nobuyuki
    Mimori, Tsuneyo
    Takeuchi, Tsutomu
    Hirata, Shintaro
    Tanaka, Eiichi
    Yasuoka, Hidekata
    Kaneko, Yuko
    Murakami, Kosaku
    Koga, Tomohiro
    Nakano, Kazuhisa
    Amano, Koichi
    Ushio, Kazuyasu
    Atsumi, Tatsuya
    Inoo, Masayuki
    Hatta, Kazuhiro
    Mizuki, Shinichi
    Nagaoka, Shohei
    Tsunoda, Shinichiro
    Dobashi, Hiroaki
    Horie, Nao
    Sato, Norihiro
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [24] Infliximab dose escalation in patients with rheumatoid arthritis in the START study: Influence of Infliximab pharmacokinetics and immunogenicity
    Rahman, M. U.
    Strusberg, I.
    Geusens, P.
    Wagner, C.
    Han, J.
    Westhovens, R.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 86 - 86
  • [25] Infliximab dose and clinical status: Results of 2 studies in 1642 patients with rheumatoid arthritis
    Stern, R
    Wolfe, F
    JOURNAL OF RHEUMATOLOGY, 2004, 31 (08) : 1538 - 1545
  • [26] Rapamycin Induces Remission in Patients with Newly Diagnosed Rheumatoid Arthritis
    Chen, Min
    Li, Xiao-Feng
    Gao, Chong
    Wang, Cai-Hong
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [27] RAPAMYCIN INDUCES REMISSION IN PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS
    Chen, M.
    Li, Z.
    Yao, H.
    Hu, F.
    Liang, J.
    Yan, N.
    Niu, H.
    Gao, C.
    Li, X.
    Wang, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1357 - 1357
  • [28] Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experience
    Cannon, G. W.
    Wang, B. C.
    Park, G. S.
    Koenig, A.
    Collier, D. H.
    Keystone, E. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (06) : 919 - 925
  • [29] TOCILIZUMAB BUT NOT INFLIXIMAB THERAPY INDUCES MYALGIA AMONG RHEUMATOID ARTHRITIS PATIENTS WITH HIGH DISEASE ACTIVITY
    Uda, H.
    Saiki, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 375 - 375
  • [30] Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial
    Dale, James
    Stirling, Anne
    Zhang, Ruiqi
    Purves, David
    Foley, Jonathan
    Sambrook, Martin
    Conaghan, Philip G.
    van der Heijde, Desiree
    McConnachie, Alex
    McInnes, Iain B.
    Porter, Duncan
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (06) : 1043 - 1050
12345